Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lloyd Mayer

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
The Journal of Biological Chemistry|February 18, 2006
IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathwaysJie Zhao, Hee Jeong Kong, Hongxing Li, et al.
Gastroenterology|October 9, 2007
A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitisScott Plevy, Bruce Salzberg, Gert Van Assche, et al.
Inflammatory Bowel Diseases|March 26, 2011
Normal response to vaccines in inflammatory bowel disease patients treated with thiopurinesIris Dotan, Lael Werner, Sharon Vigodman, et al.
Gastroenterology|June 5, 2008
Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propriaLimin Shang, Masayuki Fukata, Nanthakumar Thirunarayanan, et al.
Nature Medicine|November 22, 2011
Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gutNatalia Shulzhenko, Andrey Morgun, William Hsiao, et al.
Gut|March 7, 2013
Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised studyLloyd Mayer, William J Sandborn, Yuriy Stepanov, et al.
Clinical Immunology (Orlando, Fla.)|October 20, 2010
High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous diseaseJoyce E Yu, Suk See De Ravin, Gulbu Uzel, et al.
Blood|December 11, 2012
Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cellsTuure Kinnunen, Nicolas Chamberlain, Henner Morbach, et al.
The Journal of Biological Chemistry|July 14, 2009
AP-1 activated by toll-like receptors regulates expression of IL-23 p19Weicheng Liu, Xinshou Ouyang, Jianjun Yang, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 11, 2009
A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitisRyan Ungaro, Masayuki Fukata, David Hsu, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
The Journal of Biological Chemistry|February 18, 2006
IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathwaysJie Zhao, Hee Jeong Kong, Hongxing Li, et al.
Gastroenterology|October 9, 2007
A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitisScott Plevy, Bruce Salzberg, Gert Van Assche, et al.
Inflammatory Bowel Diseases|March 26, 2011
Normal response to vaccines in inflammatory bowel disease patients treated with thiopurinesIris Dotan, Lael Werner, Sharon Vigodman, et al.
Gastroenterology|June 5, 2008
Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propriaLimin Shang, Masayuki Fukata, Nanthakumar Thirunarayanan, et al.
Nature Medicine|November 22, 2011
Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gutNatalia Shulzhenko, Andrey Morgun, William Hsiao, et al.
Gut|March 7, 2013
Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised studyLloyd Mayer, William J Sandborn, Yuriy Stepanov, et al.
Clinical Immunology (Orlando, Fla.)|October 20, 2010
High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous diseaseJoyce E Yu, Suk See De Ravin, Gulbu Uzel, et al.
Blood|December 11, 2012
Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cellsTuure Kinnunen, Nicolas Chamberlain, Henner Morbach, et al.
The Journal of Biological Chemistry|July 14, 2009
AP-1 activated by toll-like receptors regulates expression of IL-23 p19Weicheng Liu, Xinshou Ouyang, Jianjun Yang, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 11, 2009
A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitisRyan Ungaro, Masayuki Fukata, David Hsu, et al.
Pageof 13